Handling Missing Data in Clinical Trials: An Overview

被引:0
|
作者
William R. Myers
机构
[1] Procter and Gamble Pharmaceuticals,Department of Biometrics and Statistical Sciences
[2] Procter and Gamble Pharmaceuticals,Department of Biometrics and Statistical Sciences
关键词
Clinical trials; Missing data; Dropouts; Imputation methods; Missing-data mechanism;
D O I
暂无
中图分类号
学科分类号
摘要
A major problem in the analysis of clinical trials is missing data caused by patients dropping out of the study before completion. This problem can result in biased treatment comparisons and also impact the overall statistical power of the study. This paper discusses some basic issues about missing data as well as potential “watch outs.” The topic of missing data is often not a major concern until it is time for data collection and data analysis. This paper provides potential design considerations that should be considered in order to mitigate patients from dropping out of a clinical study. In addition, the concept of the missing-data mechanism is discussed. Five general strategies of handling missing data are presented: I. Complete-case analysis, 2. “Weighting methods,” 3. Imputation methods, 4. Analyzing data as incomplete, and 5. “Other” methods. Within each strategy, several methods are presented along with advantages and disadvantages. Also briefly discussed is how the International Conference on Harmonization (ICH) addresses the issue of missing data. Finally, several of the methods that are illustrated in the paper are compared using a simulated data set.
引用
收藏
页码:525 / 533
页数:8
相关论文
共 50 条
  • [21] MISSING PATIENT REPORTED OUTCOME DATA IN CLINICAL TRIALS: AN OVERVIEW AND SIMULATION STUDY
    McGinley, J. S.
    Savord, A.
    Chan, E.
    Larbalestier, A.
    Liu, Y.
    Delong, P. S.
    Wirth, R. J.
    VALUE IN HEALTH, 2023, 26 (06) : S281 - S281
  • [22] A framework for handling missing accelerometer outcome data in trials
    Tackney, Mia S.
    Cook, Derek G.
    Stahl, Daniel
    Ismail, Khalida
    Williamson, Elizabeth
    Carpenter, James
    TRIALS, 2021, 22 (01)
  • [23] A framework for handling missing accelerometer outcome data in trials
    Mia S. Tackney
    Derek G. Cook
    Daniel Stahl
    Khalida Ismail
    Elizabeth Williamson
    James Carpenter
    Trials, 22
  • [24] Currently available guidance on missing data handling in randomized clinical trials: a scoping exercise
    Krepper, Daniela
    Martini, Caroline
    Sztankay, Monika
    QUALITY OF LIFE RESEARCH, 2022, 31 : S127 - S127
  • [25] Review of guidelines and literature for handling missing data in longitudinal clinical trials with a case study
    Liu, M
    Wei, L
    Zhang, J
    PHARMACEUTICAL STATISTICS, 2006, 5 (01) : 7 - 18
  • [26] Addressing Missing Data in Clinical Trials
    Fleming, Thomas R.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (02) : 113 - +
  • [27] MISSING DATA IN CONFIRMATORY CLINICAL TRIALS
    Flyer, Paul
    Hirman, Joseph
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (06) : 969 - 979
  • [28] Missing Data in Clinical Trials Reply
    Little, Roderick J.
    Siegel, Jay P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (26): : 2557 - 2558
  • [29] Addressing Missing Data in Clinical Trials
    van der Laan, Mark
    Lorenz, Todd J.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (02) : 135 - 135
  • [30] Methods for Missing Data Handling in Phase III Clinical Trials with Nonnormal Endpoints and Nonnormal Covariates
    Fan, Chunpeng
    Wei, Lynn
    Koch, Gary G.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2020, 12 (01): : 68 - 78